Preprint
Article

This version is not peer-reviewed.

Evaluation of Rat Testicular Cell Populations in Experimental Condition of Diabetes Induced in Early Postnatal Life

A peer-reviewed article of this preprint also exists.

Submitted:

31 July 2025

Posted:

01 August 2025

You are already at the latest version

Abstract
Diabetes mellitus (DM) causes male infertility by suppression of spermatogenesis and testosterone biosynthesis. The impact of DM on male reproduction was investigated mainly in adulthood, therefore we aimed to study developmental effects of DM, induced in early life, on testicular cell population and fertility. Neonatal (NDM) and pre-pubertal DM (PDM) were induced in immature rats by streptozotocin administration on day 1 or day 10, respectively. Germ (GCs) and somatic cells (Sertoli – SCs and Leydig cells – LCs) were counted in pubertal (25 day) and post-pubertal (45 day) rats in tandem with evaluation of serum testosterone levels and protein expression of androgen receptor. Glucose levels were higher in PDM than in NDM. SCs number was not significantly changed while GCs were reduced only in PDM as a result of incomplete spermatogenesis. Decreased number of LCs at puberty did not affect testosterone production due to higher ratio nuclear/cytoplasm volume. Later, testosterone synthesis diminished more pronounced in PDM. Protein expression of androgen receptor in SCs was altered only in PDM. Reduced sperm concentration and motility was found in both groups. Differential response of testicular cell populations in developing rats to PDM and NDM was suggested associated with altered androgen production and action.
Keywords: 
;  ;  ;  ;  

1. Introduction

Diabetes mellitus (DM) is a chronic complicated metabolic disorder characterized by hyperglycemia, which often results from defects in insulin secretion, insulin action, or both. According to the International Diabetes Federation, approximately 589 million adults were living with type 1 DM (T1DM) and type 2 (T2DM) in 2024; and it estimates that by 2050 this number will increase to 853 million. More than 1.8 million children and adolescents are living with T1DM worldwide, and there is a continuous increase in the number of young patients with T1DM and T2DM [1]. The increased incidence of T1DM has been associated with falling birth rates and compromised fertility [2].
A large number of studies, both in diabetic men and animal models indicate that DM causes male infertility via action at multiple levels including altered spermatogenesis, degenerative and apoptotic changes in the testes, altered glucose metabolism in Sertoli cells/blood testes barrier, reduced testosterone synthesis and secretion, ejaculatory dysfunction and reduced libido [3]. In men with chronic diabetes and obesity, late-onset hypogonadism syndrome is more popular. Real obstacle to conduct studies on human male is for ethical reasons, e.g. nearly no testicular biopsies were available, therefore no systematic histopathology or molecular data from human testis of patients with DM can be available [4]. Therefore, the use of animal models has been crucial to provide more detailed molecular and cellular insight on the effect of hyperglycaemia on the male reproductive system and fertility.
Many animal studies have employed streptozotocin (STZ)-induced diabetes as STZ is the most prominent diabetogenic chemical that is widely used in experimental animals for creating animal models of type 1 and type 2 diabetes [5,6]. STZ is a naturally occurring compound, produced by the soil bacterium Streptomyces achromogenes that easily enters the pancreatic beta cells through Glucose transporter-2, causing alkylation/damage of the DNA and subsequent cell death resulting in rapid hyperglycaemia. STZ is proven to be a better diabetogenic agent than alloxan with wider species effectiveness and greater reproducibility [7]. Moreover, the STZ model mimics many of the acute and chronic complications of human diabetes and gives the established similarities of some of the structural, functional and biochemical abnormalities to human disease. Hence, it is an appropriate model to assess the mechanism of diabetes.
The mammalian testis is a complex multicellular organ, separated into two distinct compartments which carry out its principle functions. In the adult testis, spermatogenesis and sperm production occur within the seminiferous tubules, and androgen biosynthesis (steroidogenesis) occurs in Leydig cells located in the interstitium.
Two major events of the testis development that occurred during sexual maturation are the establishment of spermatogenesis and the development of the adult Leydig cell population responsible for androgen production. Spermatogenesis in mammals is a dynamic and highly regulated process that encompasses numerous proliferating and differentiating steps from spermatogonia to spermatozoa resulting in production of the male gametes [8].
Androgens are especially important for male sexual differentiation in fetal life, pubertal sexual maturation and the maintenance of spermatogenesis in adulthood. The effects of androgens are mediated through the androgen receptor (AR) that binds testosterone (T) with high affinity. In the testis AR is localized in peritubular cells, Leydig cells (LCs) and Sertoli cells (SCs) but not in germ cells (GCs). Preferential action of androgens at stages VII-VIII of the spermatogenic cycle of the rat coincided with the maximal expression of AR protein in Sertoli cells suggesting that androgen support for spermatogenesis is primarily mediated through the Sertoli cells [9] – a conclusion that was supported by knockout models for selective ablation of AR in Sertoli cell (SCARKO mice) [10].
Sertoli cells are involved in the regulation of spermatogenesis, providing nutritional support for germ cells. Glucose metabolism in Sertoli cells produces lactate for germ cells, which is crucial for spermatogenesis and in particular it is consumed by pachytene spermatocytes and round spermatids [11]. Germ cells are highly reliant on carbohydrate metabolism as they need energy for their differentiation. However, metabolic stressors such as diabetes, impair glucose transport and lactate production, compromising energy supply. Hyperglycaemia has been shown to affect glucose uptake and lactate production by Sertoli cells by reducing follicle-stimulating hormone (FSH) and testosterone levels [12].
Recent reviews have summarized a lot of data on metabolic and signal pathways of DM action on male reproductive function. The main mechanism of DM is induction of oxidative stress and inflammation and in many papers the role of molecules involved in these pathophysiological processes was discussed in relation to semen pathology/sperm characteristics and male infertility and profiles of reproductive hormones [12,13,14]. Less data are published about the effect of DM on cellular composition of the testis and their functions. The investigations mainly used experimental models for T1DM induced in adulthood. Limited number of studies utilized neonatally induced DM as a model for T2DM but material taken for investigation was from adult animals. Two papers are published about the effect of DM induced in neonatal or pubertal age (day 15) on developing testis suggesting that more pronounced alterations occur in early-life induced DM compared to DM induced in adulthood [15,16].
Early postnatal period is crucial for establishment of spermatogenesis – resuming of mitotic division of precursors germ cells on day 4.5 (pre-spermatogonia) giving rise differentiated spermatogonia followed by start of meiosis on day 12 in rat [17]. In this respect our interest was focused on the developmental effect of early DM induced neonatally on day 1 (NDM as it is applied to induced T2DM in adulthood), or prepubertally on day 10 (PDM). Hence, the aim of the present study is to follow the postnatal development of testicular germ and somatic cells (Leydig cells and Sertoli cells) in condition of experimentally induced NDM or PDM in relation to androgen production and action. The current work presents comparative evaluation of the impact of two types of DM providing new knowledge on differential effects of early postnatal DM on developing testicular cell populations and the first wave of spermatogenesis.

2. Materials and Methods

2.1. Animal Model

The experimental protocol was performed at the Institute of Experimental Morphology, Pathology and Anthropology with Museum, Bulgarian Academy of Sciences according to the ARRIVE guidelines and EU Directive for animal experiments. The study was approved by the Bulgarian Agency for Food Safety, Approval number 282 from 24.09.2020.
Pregnant Wistar rats were purchased from the experimental and breeding base for laboratory animals (EBBLA) (Slivnitza, Bulgaria). Mothers were separated into individual standard hard-bottom polypropylene cages, fed a standard diet and had access to food and water ad libitum. After birth, the pups were i.p. injected with streptozotocin (STZ, Sigma-Aldrich, S0130) at a single dose of 100 mg/kg b.w. (dissolved in ice cold 0.1 M citrate buffer, pH 4.5) on day 1 to induce neonatal diabetes mellitus (NDM) or on day 10 to induce prepubertal diabetes mellitus (PDM). Control age-matched animals were injected with citrate buffer. Two days after STZ injection, the blood glucose was measured using a glucometer (Accu-chek Performa, Roshe). Hyperglycaemic status was confirmed by blood glucose level > 15 mmol/L.
At weaning (day 25) the offspring were separated from their mothers to the end of the protocol. Investigated groups consist only of male rats (n = at least 6). The rats were sacrificed (Small Animal Decapitator, Stoelting™ 51330) under light anaesthesia on postnatal days 25 (puberty) and 45 (post puberty/early adulthood). Blood was obtained after decapitation and serum was stored at -80°C for subsequent analysis. Both testes were excised and the left testis was fixed in Bouin solution, dehydrated and embedded in paraffin for further histological studies.

2.2. Measurement of Body and Testis Weight

The body weight of the animals was measured before sacrifice. Testes of control and experimental rats were excised, weighed and relative testis weight (gonado-somatic index) was calculated as a ratio of average weight of both testes to body weight, multiplied by 100.

2.3. Measurement of Serum Glucose

Glucose levels (nonfasting on day 25 and fasting on day 45) were evaluated in serum of control and diabetic animals by commercial kits (Chema Diagnostica, Italy) on biochemical analyzer BA-88 (Mindray, China).

2.4. Measurement of Serum Testosterone and Serum Luteinizing Hormone

Serum testosterone and serum luteinizing hormone (LH) levels were evaluated by enzyme-linked immunosorbent assay (ELISA) according to the instructions of the kit manufacturer (Elabscience Biotechnology Co., Ltd, China). Competitive ELISA for testosterone (Cat. № E-EL-0155) and sandwich-ELISA for luteinizing hormone (Cat. № E-EL-R0026) were performed. The optical density was read at 450 nm on an ELISA Reader BioTek (BioTek Instruments, Winooski, VT, USA). Curve Expert Professional 2.7 software was used. The final concentration of testosterone was calculated in ng/mL. The final concentration of luteinizing hormone was multiplied by the dilution factor (x6) and calculated in mlU/mL.

2.5. Stereological Analyses

For morphometric/stereological analyses of germ and Sertoli cells, Bouin’s fixed, 5 µm paraffin embedded tissue sections were stained with hematoxylin and eosin (H&E). For Leydig cells enumeration, tissue sections were immunostained for 3β-hydroxysteroid dehydrogenase (3β-HSD) that is specific marker for steroid-producing cells. Testicular cell composition was estimated using standard stereological techniques involving point counting of cell nuclei to determine the nuclear volume per testis of Sertoli cells, Leydig cells and different maturational stages of germ cells, as previously described [18]. In brief, cross-sections of testes were examined using 63x objective and a 121-point eyepiece graticule (Leica Microsystems,Wetzlar, Germany) fitted to Zeiss AxioScope A1 microscope. Applying a systematic sampling pattern from a random starting point, 32 microscopic fields (3872 points) were counted for each animal. Points falling over Leydig cells, Sertoli cells, or germ cell nuclei (including spermatogonia, spermatocytes, round and elongated spermatids), seminiferous epithelium, interstitium, and seminiferous tubule lumen were scored and they were expressed as relative (%) volume per testis. Values for percent nuclear volume were converted to absolute nuclear volume (ANV) per testis by reference to testis volume (=weight) because shrinkage was minimal. Cell nuclear volume can be equated to numbers of cells per testis, assuming no change in nuclear diameter of the target cell in the different experimental groups [10,18].

2.6. Immunohistochemistry (IHC) for Androgen Receptor (AR), 3β-Hydroxysteroid Dehydrogenase (3β-HSD) and Testicular Angiotensin Converting Enzyme (tACE)

Unless otherwise stated, all incubations were performed at room temperature. The deparaffinized and rehydrated 5 μm sections of control and experimental testes were subjected to a temperature-induced antigen retrieval step in 0.01 M citrate buffer, pH 6.0 - tACE, AR and 3β-HSD. Endogenous peroxidase activity was blocked by immersing all sections in 3% (vol/vol) H2O2 in methanol for 30 min, followed by two 5-min washes in Tris-buffered saline (TBS). To block nonspecific binding sites, sections were incubated for 30 min with 10% blocking serum in TBS containing 5% bovine serum albumin (BSA): for AR it was normal swine serum; for tACE and 3β-HSD – normal rabbit serum. After that primary antibodies were added to the sections at appropriate dilutions in blocking serum and incubated overnight at 4°C in a humidified chamber. Antibodies were applied as follow: rabbit polyclonal anti-androgen receptor (N-20; sc-816 Santa Cruz Biotechnology, Inc. USA), diluted 1:200; goat polyclonal anti-tACE (sc-12187, Santa Cruz Biotechnology, Inc), diluted 1:500; goat polyclonal anti-3β-HSD (P-18; sc-30820, Santa Cruz Biotechnology, Inc), diluted 1:500. After two 5-min washes in TBS, sections were incubated with biotinylated secondary antibodies as follow: for AR - swine anti-rabbit (dilution 1:500, DAKO Cytomation, Denmark); for tACE and 3β-HSD - rabbit anti-goat (Vector BA-5000) for 30 min. After two additional 5-min washes in TBS, sections were incubated for 30 min with avidin-biotin conjugated to horseradish peroxidase (ABC Reagent, Vector Laboratories Inc., USA). Sections were washed twice in TBS, and immunostaining was developed using 3,3’-diaminobenzidine (liquid DAB; DAKO Corp.) The sections were counterstained with hematoxylin, dehydrated before mounting and observed under a light microscope Zeiss AxioScope.A1 (Carl Zeiss, Germany).
Negative controls were ran in parallel by omitting the primary antibody under the same conditions. For AR the negative control was done also by preabsorption of primary antibody with peptide immunogen sc-816P.

2.7. Semen Analysis

The sperm characteristics were evaluated by computer-assisted sperm analysis (SCA®, Sperm Class Analyzer, Microptic®, Spain). Briefly, the semen samples were collected from both cauda epididymides of control and diabetic rats (NDM and PDM) and placed in pre-warmed (37°C) HEPES solution (pH 7.4). After incubation at 37°C for 20 min, 5 μL of each sample were transferred to a chamber Leja 20 (Leja Products B.V., Nieuw-Vennep, The Netherlands) and were analyzed using a microscope (Nikon Eclipse E200, Nikon) with 10× objective (Nikon 10×/0.25 Ph1 BM, Nikon) under negative phase contrast and camera with high resolution (768 × 576 pixels). All samples were evaluated twice to determine the sperm concentration and motility (percentage of sperm moving faster than 10 µm/s).

2.8. Statistical Analysis

The obtained data were processed using SPSS 16.0 for Windows. The results are presented as mean value ± standard error (SE). Statistical significance between the experimental groups was assessed using one-way ANOVA and p<0.05 was considered to be statistically significant.

3. Results

3.1. Serum Glucose Levels and Diabetic Status

Diabetic status on day 25 (puberty) and day 45 (post puberty/early adulthood) was validated by an increase in serum glucose levels. On day 25 NDM rats were normoglycaemic whereas on day 45 serum glucose level was increased by 27% compared to control. In contrast, PDM animals were hyperglycaemic at both ages much more evident on day 45 when glucose level was elevated by more than 90% (Table 1).

3.2. Body Weight, Absolute and Relative Testis Weights

Body weight of 25-day-old pubertal rats was not changed in PDM and slightly increased in NDM – by 13%. Diabetic rats aged 45 days were heavier than control animals and the significant increment in body weight was more pronounced in NDM (> 50%) compared to PDM where the value was increased by less than 10%.
The absolute testis weight on day 25 was not affected by NDM and the relative testis weight (gonado-somatic index), expressed as testis weight to body weight ratio, decreased insignificantly by 18% compared to control. However, PDM caused 30% significant reduction in both absolute and relative testis weights in pubertal 25-day-old animals. By the end of puberty and early adulthood (day 45) NDM caused significant increase by 20% in absolute testis weight while the relative testis weight was significantly lower by 20% than control. In post pubertal PDM (day 45) animals both absolute and relative testis weights were significantly reduced in similar extent (by 25-30%) compared to the control values (Figure 1A and Figure 1B).
The absolute volumes of interstitium, seminiferous epithelium and lumen in NDM and PDM rats on day 25 follow the trend of testis weight. In 45-day-old NDM animals the volumes of seminiferous epithelium and tubular luminal were increased compared to control. The elevation of luminal volume was more than 2-fold compared to the control but statistical significance was not reached due to high variation between animals within the NDM group (in three from 6 animals the lumen was expanded). In PDM group the three parameters decreased with significance found for seminiferous epithelium (Table 2).

3.3. Morphology of the Testis and Proceeding of Spermatogenesis by Visualization of Elongating Spermatids by Testicular Angiotensin-Converting Enzyme (tACE)

Morphological observation on day 25 revealed intact histology of testis in both diabetic groups (NDM and PDM). At this age spermatogenesis proceeds to stage of late pachytene and diplotene spermatocytes. On day 45 spermatogenesis in control rats is completed as evident by the presence of full complement of germ cells (from spermatogonia to spermatozoa) and their associations through all 14 stages of the cycle of the seminiferous epithelium. Although release of spermatozoa into the tubular lumen can be seen in the middle stages (VII-VIII) of the cycle, the rats are not considered as sexually matured as spermatozoa cannot be isolated from cauda epididymis. Morphological changes in the testis of diabetic rats were demonstrated by visualization of testicular angiotensin-converting enzyme (tACE), known as a specific marker for elongating spermatids (step 8 to step 19 of spermiogenesis) that is expressed in a stage specific manner. The low intensity of protein expression appeared in the cytoplasm of elongating spermatids step 9 at stage IX of the spermatogenic cycle followed by gradual increase at late (XII-XIV) and early stages (I-VI) with maximal extent of the expression at stage VII-VIII (in step 19 elongating spermatids, the final step of spermiogenesis).
Differences in testicular histology were observed between 45-day-old NDM and PDM rats where the germ cell complement of the seminiferous tubules was altered. Spermatogenesis is completed in NDM but not in PDM animals. Moreover, different degree of delay in spermatid development was observed in PDM rats (Figure 2). It was indicated by lack of elongating spermatids in early stages IV-VII (Figure 2B) or in all the early stages (I-VII; Figure 2C) or total loss of elongating spermatids in all fourteen stages (I-XIV; Figure 2D). Germ cell depletion, mainly round spermatids in some seminiferous tubules, was also found.

3.4. Quantification of Spermatogenesis. Germ and Sertoli Cell Counts

Seminiferous tubules in the testis comprise Sertoli cells and different types of developing/differentiating gem cells. Our data for Sertoli cell count revealed that on day 25 the absolute nuclear volume (ANV) in both diabetic groups (NDM and PDM) was not different from the control (Figure 3A). On day 45 the Sertoli cell ANV was insignificantly altered by the hyperglycaemia – the mean value was higher (by 20%) in NDM group and lower (by 30%) in PDM group (Figure 3B).
Total germ cell ANV was calculated as a sum of ANV of spermatogonia, spermatocytes and spermatids (round spermatids, step 1-8 and elongating spermatids, step 9-14). In controls germ cell complement on day 25 comprised spermatogonia and spermatocytes and on day 45 – spermatogonia, spermatocytes and spermatids. The total germ cell ANV was insignificantly increased at both ages in NDM groups compared to the controls, more pronounced on day 45 (by 18%) than on day 25 (by 9%) (Figure 3B). In contrast, in PDM rats the total germ cell ANV was reduced at both ages more pronounced on day 45 (significantly by 25%) than on day 25 (insignificantly by 20%).
As Sertoli cell volume per testis was altered, although insignificantly in 45-day-old NDM and PDM rats, data for germ cell volume were expressed relatively to the Sertoli cell volume to derive a measure of the efficiency of Sertoli cell support for spermatogenesis. This ratio provides data about how many germ cells are supported by one Sertoli cell. The mean values of this parameter in NDM (12.99 ± 1.25) and PDM (14.02 ± 0.85) were nearly to the control value (13.30 ± 2.17).
On day 65 semen analysis was performed on spermatozoa isolated from both cauda epididymides of control and diabetic rats. Sperm concentration was lower by 20% and 25% compared to control samples in PDM and NDM, respectively. Similar decrease was established for sperm motility (%) - by 20% and 30% compared to control in PDM and NDM, respectively. High percentage of round-shaped undifferentiated cells were seen in NDM (11.48 ± 1.83) but not as much in PDM (4.11± 0.56) whereas in control samples they are 0.90 ± 0.13 (Figure 4).

3.5. Leydig Cell Counts and Measurements of Testosterone Levels

Leydig cells counts were performed after visualization by specific steroidogenic marker enzyme 3β-hydroxysteroid dehydrogenase (Figure 5). The enzyme catalyzes the conversion of Δ5-3β-hydoxysteroids to the Δ4-3-ketosteroids thus is considered as a key enzyme in androgen biosynthesis.
Quantification of Leydig cells in the testicular interstitium on day 25 and day 45 revealed reduction in ANV in both diabetic groups that reached statistical significance in 45-day-old PDM rats. The decrease in ANV of Leydig cells was more pronounced in PDM group compared to NDM. The reduction of Leydig cells ANV was similar in PDM rats on day 25 and day 45 compared to the controls (by 55-60%) (Figure 6A and A).
Serum testosterone concentrations were not changed in 25-day-old NDM and PDM groups (Figure 6A). However, on day 45 testosterone levels were reduced by 31.5% in NDM and by 51% in PDM rats compared to the controls (Figure 7A) but the differences were not statistically significant due to variable values within the groups. Statistical significance was reached in adult 65-day-old PDM group (decrease by 63.5%) (data not shown).
In order to explain normal testosterone levels in 25-day-old diabetic groups when LC ANV was reduced, we calculated ratio of absolute nuclear to cytoplasm volume of Leydig cells. Interestingly, the ratio was higher by 13% in NDM (3.15 ± 0.42) and by 37% in PDM (3.84 ± 0.68) groups compared to control (2.80 ± 0.58).
Serum LH concentrations were elevated in both pubertal groups compared to the control, more pronounced in NDM (by 65%) than PDM (by 16%) (Figure 6B). In post-pubertal rats the hormone levels were reduced insignificantly by 12% and 20% in NDM and PDM, respectively (Figure 7B).

3.6. Protein Expression of Androgen Receptor in the Testis

In 45-day-old control rats, androgen receptor is localized in the nuclei of Sertoli cells, Leydig cells and peritubular cells but not in germ cells. As we previously reported stage-specific protein expression of AR was evident in the nuclei of Sertoli cells through the fourteen stages of the spermatogenic cycle in adult rats [19]. The intense expression was seen at early stages (I-VI) with maximum at stage VII-VIII of the cycle while the lowest expression was found at stages IX-XIV (Figure 8D). In pubertal control testis (day 25) when spermatogenesis is not completed the stage specificity of AR protein expression in Sertoli cells was not pronounced (Figure 8A). NDM did not produce any changes in AR protein expression in Sertoli cells. (Figure 8B and Figure 8E). In PDM rats weaker intensity of AR immunostaining in Sertoli cells was observed on day 25 and stage specificity of AR expression was not evident on day 45 when uniform immunoreactivity in the tubules from all the stages was found (Figure 8C and Figure 8F).

4. Discussion

During the last two decades a large number of studies both on diabetic men and experimental diabetic animals have been published on the impact of DM on male reproduction but many of them have conflicting results. Prevailing notion is that DM alters spermatogenesis, sperm parameters, biosynthesis of testosterone and induces degenerative changes in the testis that lead to sub-fertility or infertility. Although extensive research has been done on experimental models for induction of DM in adulthood (sexually maturity), the studies on the effect of hyperglycaemia on immature animals are very limited.
Early postnatal period is known to be critical for development of male germ cells when after prolonged resting period in fetal and neonatal life, the precursors of germ cells (pre-spermatogonia) resume mitotic division on day 4.5 in rat giving rise to differentiated spermatogonia. The latter proceed to series of consecutive divisions to enter the first prophase of meiotic division with formation of primary spermatocytes that occurs on day 12 in rat. Both major events are crucial for establishment of spermatogenesis and any interference during this time results in poor reproductive capacity and infertility [17]. Aside from initiative role of pituitary gonadotrophic hormones and androgen locally produced in the testis, insulin might also have a direct action on testicular cell composition. Germ cells are highly dependent on carbohydrates needed for energy homeostasis being vulnerable to any disturbance in glucose metabolism [12,20].
By evaluating the impact of DM induced in early life, the current study promises to provide new data suggesting that neonatal or prepubertally induced hyperglycaemia may exert differential effects on testicular cell populations (germ and somatic cells) during the first wave of spermatogenesis that results in poor semen quality.
Based on glucose levels, 25-day-old NDM rats in our study were normoglycaemic, as expected [see King, 2012 [5] for neonatally induced T2DM] and later they developed mild hyperglycaemia. In contrast, PDM animals were hyperglycaemic on day 25. As hyperglycaemia became more severe on day 45, PDM rats might be considered as T1DM model.
Day 25th in rats is considered as mid-puberty and spermatogenesis proceeds to late pachytene-diplotene spermatocytes. Day 45th is post-puberty/early adulthood as spermatogenesis is completed but without sperm ejaculation and therefore animals are still immature.
Quantification of total germ cell population revealed different effects of both types of DM. NDM resulted in an increase in total germ cell absolute nuclear volume (TGC-ANV) at both ages by 9% – 18% compared to controls while PDM caused a decrease in this parameter by 75%. Limited data are available that the germ cell number was reduced in adult animals with T1DM or T2DM induced by different treatment protocols (high fat diet (HFD) or nicotinamide (NAD) plus STZ as well drinking of fructose [21,22,23,24,25]. In the few papers published on neonatally induced DM there are no data about testicular cell numbers. Comparatively study by Barsiah et al. [21] demonstrated more pronounced reduction in total cell number in seminiferous tubules (germ and Sertoli cells) by T1DM than adult T2DM. Our new data for germ cell counts suggest different (opposite) effects on spermatogenesis caused by both types of DM – decrease v/s increase of GC-ANV in PDM and NDM, respectively.
Evaluation of proceeding of spermatogenesis in post-pubertal diabetic rats (45-day-old) demonstrated for the first time delayed development of late stages in spermatogenesis (post-meiotic stages – round and elongated spermatids) in post-pubertal PDM but not in NDM rats. Germ cell depletion mainly of round spermatids also contributes to decreased germ cell number in PDM. It seems that germ cells are more vulnerable to PDM than to NDM that could be explained by different glucose profiles and different time of administration of STZ. PDM is induced at time of active proliferation of spermatogonia before entering meiosis while NDM is induced during quiescent period (mitotic arrest) of precursor spermatogonia (pre-spermatogonia). The authors cited in the paragraph above induced T1DM or T2DM by different treatment regimens and investigation was conducted on adult animals. That could explain our different finding for increased total ANV of GCs in NDM.
Many studies indicated that apoptosis and oxidative stress in tandem with inflammation are responsible for germ cell loss in diabetic conditions (summarized in review articles [12,13,14]. Recently, we reported increased protein expression of pro-apoptotic factor Bax, more pronounced in PDM than NDM rats and these data could provide explanation for the decreased TGC-ANV in PDM animals (by 25%) [26]. Also, the levels of some molecular markers for oxidative stress (3-Nitrotyrosine, 3-NT and 4-hydroxynonenal, 4-HNE) were elevated more in PDM than in NDM that is associated with increased protein expression of pro-inflammatory marker, tumor necrosis factor alpha (TNF-α) [27].
To follow the consequences of impaired spermatogenesis on fertility, we evaluated semen parameters (sperm count/concentration and sperm motility) on day 65 in both diabetic groups. The sperm count and sperm motility decreased in similar extent in PDM and NDM. An extremely high number of round shaped abnormal undifferentiated cells were counted (11-fold increase) in NDM but not in PDM that might be a reason for decreased sperm parameters in NDM despite no obvious destructive changes in post-pubertal 45-day-old rats. Most of the papers reported decreased sperm concentration and motility in T1DM [25,28,29,30] and in T2DM [22] but data from NDM in adulthood are contradictory – decreased semen parameters [16] v/s increased sperm concentration [31].
There is a general agreement that changes in absolute testis weight reflect those in TGC-ANV and our results support this finding. Interestingly, the relative testis weight decreased in NDM and PDM animals on days 25 and 45. Although both testis weight and body weight were elevated in NDM the increment in body weight was higher than that in testis weight. Most of the data in the literature indicate lower absolute testis weight in adult rodents with T1DM and T2DM measured in adulthood. Barsiah et al. [21] reported decreased testis weight only in adult animas with T1DM but not in T2DM - a finding that fits to our results for increased testis weight in NDM post-pubertal rats. We also found higher volume of seminiferous epithelium (SE) in 45-day-old NDM rats in contrast to lower value in PDM. Interestingly, luminal volume of seminiferous tubules (ST) was twice increased in NDM but decreased in PDM. There are discrepancies in the literature data regarding the testicular macro-parameters due to different treatment regimens. Some studies reported decrease in SE volume, ST and lumen diameter in diabetic rats [24] while others found elevation in their values [21,29].
Sertoli cells are essential for developing germ cells to sustain spermatogenesis by providing them unique microenvironment, physical support, growth factors and appropriate nutrients, including glucose. Any metabolic alteration in these cells derived from DM may be responsible for impaired spermatogenesis resulting in compromised fertility. These cells have a glucose sensing machinery that reacts to hormonal fluctuations and several mechanisms to counteract hyper/hypoglycemic events [20]. Extensive research has been done on the expression of molecular markers for oxidative stress and inflammation including innate immune response in condition of hyperglycaemia [11,32]. Less data are available on quantitative aspects of adult Sertoli cells in conditions of DM but none are available for Sertoli cells of developing testis. Our data revealed that at pubertal age NDM and PDM did not produce changes in SC-ANV, which was later insignificantly decreased in PDM. Reduced number of SCs and GCs was reported in adult T1DM and T2DM associated with increased apoptosis [22,24,25,33]. A possible explanation for the higher SC-ANV in NDM post-pubertal rats in our study might be explained by the higher absolute testis weight. Increased Sertoli cell number was demonstrated by Tavares et al. [34] in in vitro studies on neonatal mouse organ cultures as well on TM4 Sertoli cell line treated by D-glucose. An important indicator for Sertoli cell support toward germ cells is the ratio of TGC-ANV/ SC-ANV [18] and in the current study we did not find any evidence for altered Sertoli cell supportive function.
Sertoli cells have long been considered the prime candidates of androgen regulation of spermatogenesis because of specific expression of AR through the stages of seminiferous epithelium. The current study did not find any changes in AR expression in Sertoli cells in pubertal 25-day-old DM rats. Later, at post-pubertal stage when spermatogenesis is completed, the stage-specific pattern in Sertoli cells was not maintained in PDM. Instead, an uniform pattern of AR expression was seen as a result of increased expression in the late stages of spermatogenic cycle. Such a phenomenon we have reported in other experimental condition of hormonal manipulation as androgen withdrawal [19]. A possible compensatory mechanism of androgen signaling could be suggested as it is essential for developing germ cells in condition of compromised androgen production in PDM. According to Ballester et al. [35] AR protein levels (measured by Western blot) were not changed in T1DM adult rats while Favaro et al. [36] found reduced expression of AR in prostate epithelium (reduced number of AR positive cells and protein levels in tissue homogenates).
Leydig cells are known to drive spermatogenesis via synthesis and secretion of testosterone after stimulation by pituitary luteinizing hormone. Testosterone in turn acts on Sertoli cells to establish unique environment for normal progression of germ cells through the spermatogenic cycle [8]. Experimental manipulations for androgen deficiency provided evidence for reduced size of adult Leydig cell population [18]. After visualization by specific LC marker (3β-HSD) we found reduced ANV of Leydig cells (LC-ANV) in pubertal and post-pubertal NDM and PDM rats compared to controls that was more pronounced in PDM. Intact testosterone production in both pubertal DM groups could be explained by increased ratio of nuclear to cytoplasm volume indicative that LCs are functionally more active in conditions of hyperglycaemia. In later life we found that the changes in testosterone concentration corresponded to that in LC-ANV and the reduction in both parameters was more pronounced in PDM than in NDM. The elevation in LH levels in both diabetic groups could be interpreted as a compensatory mechanism for providing stimuli to the LCs (decreased in number) so that they can maintain normal testosterone production. There are some discrepancies between data on LC number and T biosynthesis in T1DM and T2DM diabetic models. Most of the studies demonstrated decreased number of Leydig cells (LCs were not specifically immunostained and were not distinguished correctly from other cell types in the interstitium) as well as reduced serum T levels [24,25,33,35]. In these studies reduced number of Sertoli and germ cells were also found together with elevated apoptosis. In other studies Leydig cell hypertrophy or hyperplasia and decreased T levels were reported [15,37]. In addition, low levels of testosterone and pituitary gonadotropic hormones (FSH and LH) were summarized in recent review articles [12,13,38]. Down-regulation of the expression of key genes of androgen biosynthesis is involved in suppression of testosterone production in Leydig cells [39,40]. One paper reported different hormonal profiles between adult T1DM and T2DM [21] – decreased serum gonadotrophins in T1DM but not in T2DM. Our results imply that adult LCs underwent more pronounced negative changes in PDM than in NDM.

5. Conclusions

In the current study, we applied a new approach for comparative evaluation of development of testicular cell populations in condition of hyperglycaemia induced at different time points of early postnatal development when two crucial events for the establishment of spermatogenesis occur. NDM and PDM models in developing rats provide new data for differential response of testicular cell types (germ cells, Sertoli cells and Leydig cells) to hyperglycaemia depending on the time of induction of hyperglycaemia (neonatally or prepubertally). Moreover, differential response of the testis is related to different glucose profiles in developing animals. However, PDM and NDM may have similar effects on some end points like relative testis weight, germ cell/Sertoli cell ratio and semen parameters. Thus, our data provide new insights into the mechanism of action of early DM on developing germ cells that involved disturbances in androgen production by Leydig cells and androgen action in Sertoli cells. In this respect, NDM and PDM could be useful models for research on diabetes and reproductive health.

Author Contributions

Conceptualization, Ek.P. and N.A.; Methodology, Ek.P., R.I., D.A., Y.G., Em.P., I.V. and E.L.; Investigation, Ek.P., R.I., D.A., Y.G., Em.P., I.V. and E.L.; Writing—Original Draft Preparation, Ek.P. and N.A.; Writing—Review and Editing, N.A.; Visualization, Ek.P.; Supervision, N.A.; Project Administration, N.A.; Funding Acquisition, N.A.; Data Analysis, Ek.P., R.I., D.A., Y.G., Em.P., I.V. and N.A. All authors have read and agreed to the published version of the manuscript.

Funding

The study was funded by the Bulgarian National Science Fund - Grant No. KP-06-N71/7 from 08.12.2024.

Institutional Review Board Statement

This experimental design was carried out in accordance with ARRIVE guidelines for animal experiments. All applicable international, national, and/or institutional guidelines for the care and use of animals were followed. The study was approved by the Bulgarian Agency for Food Safety, Approval number 282 from 24.09.2020.

Informed Consent Statement

Not applicable.

Data Availability Statement

All data needed to understand this study are included in the manuscript.

Acknowledgments

The authors are grateful to Anastasija Ilovska for technical assistance.

Conflicts of Interest

The authors declare no conflicts of interest.

Abbreviations

The following abbreviations are used in this manuscript:
DM Diabetes mellitus
T1DM Type 1 diabetes mellitus
T2DM Type 2 diabetes mellitus
STZ Streptozotocin
DNA Deoxyribonucleic acid
AR Androgen receptor
T Testosterone
GCs Germ cells
FSH Follicle-stimulating hormone
NDM Neonatally induced diabetes mellitus
PDM Prepubertally induced diabetes mellitus
i.p. Intraperitoneal
b.w. Body weight
ELISA Enzyme-linked immunosorbent assay
IHC Immunohistochemistry
3β-HSD 3β-hydroxysteroid dehydrogenase
tACE Testicular angiotensin converting enzyme
TBS Tris buffered saline
BSA Bovine serum albumin
HEPES N-2-hydroxyethylpiperazine-N-2-ethane sulfonic acid
ANV Absolute nuclear volume
LC Leydig cell
LH Luteinizing hormone
HFD High fat diet
NAD Nicotinamide adenine dinucleotide
GC-ANV Germ cell absolute nuclear volume
TGC-ANV Total germ cell absolute nuclear volume
3-NT 3-nitrotyrosine
4-HNE 4-hydroxynonenal
TNF-α Tumor necrosis factor α
SE Seminiferous epithelium
ST Seminiferous tubules
SC Sertoli cell

References

  1. Ogle, G.D.; Wang, F.; Haynes, A.; Gregory, G.A.; King, T.W.; Deng, K.; Dabelea, D.; James, S.; Jenkins, A.J.; Li, X.; et al. Global Type 1 Diabetes Prevalence, Incidence, and Mortality Estimates 2025: Results from the International Diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0. Diabetes Res. Clin. Pract. 2025, 225, 112277. [Google Scholar] [CrossRef] [PubMed]
  2. Lutz, W. Fertility Rates and Future Population Trends: Will Europe’s Birth Rate Recover or Continue to Decline? Int. J. Androl. 2006, 29, 25–33. [Google Scholar] [CrossRef] [PubMed]
  3. Jangir, R.; Jain, G. Diabetes Mellitus Induced Impairment of Male Reproductive Functions: A Review. Curr. Diabetes Rev. 2014, 10, 147–157. [Google Scholar] [CrossRef]
  4. Maresch, C.C.; Stute, D.C.; Alves, M.G.; Oliveira, P.F.; De Kretser, D.M.; Linn, T. Diabetes-Induced Hyperglycemia Impairs Male Reproductive Function: A Systematic Review. Hum. Reprod. Update 2018, 24, 86–105. [Google Scholar] [CrossRef]
  5. King, A.J. The Use of Animal Models in Diabetes Research. Br. J. Pharmacol. 2012, 166, 877–894. [Google Scholar] [CrossRef]
  6. Ghasemi, A.; Jeddi, S. Streptozotocin as a Tool for Induction of Rat Models of Diabetes: A Practical Guide. EXCLI J. 22Doc274 ISSN 1611-2156 2023. [Google Scholar] [CrossRef]
  7. Eleazu, C.O.; Eleazu, K.C.; Chukwuma, S.; Essien, U.N. Review of the Mechanism of Cell Death Resulting from Streptozotocin Challenge in Experimental Animals, Its Practical Use and Potential Risk to Humans. J. Diabetes Metab. Disord. 2013, 12. [Google Scholar] [CrossRef]
  8. Sharpe, R.M. Regulation of Spermatogenesis. In The Physiology of Reproduction; Knobil, E., Jimmy, N., Eds.; Raven Press: New York, 1994; pp. 1363–1434. ISBN 978-0-7817-0086-3. [Google Scholar]
  9. Bremner, W.J.; Millar, M.R.; Sharpe, R.M.; Saunders, P.T. Immunohistochemical Localization of Androgen Receptors in the Rat Testis: Evidence for Stage-Dependent Expression and Regulation by Androgens. Endocrinology 1994, 135, 1227–1234. [Google Scholar] [CrossRef]
  10. De Gendt, K.; Swinnen, J.V.; Saunders, P.T.K.; Schoonjans, L.; Dewerchin, M.; Devos, A.; Tan, K.; Atanassova, N.; Claessens, F.; Lécureuil, C.; et al. A Sertoli Cell-Selective Knockout of the Androgen Receptor Causes Spermatogenic Arrest in Meiosis. Proc. Natl. Acad. Sci. 2004, 101, 1327–1332. [Google Scholar] [CrossRef]
  11. Alves, M.G.; Martins, A.D.; Rato, L.; Moreira, P.I.; Socorro, S.; Oliveira, P.F. Molecular Mechanisms beyond Glucose Transport in Diabetes-Related Male Infertility. Biochim. Biophys. Acta BBA - Mol. Basis Dis. 2013, 1832, 626–635. [Google Scholar] [CrossRef]
  12. Chen, Z.; Shen, Y.; Gao, D.; Lin, D.; Ma, W.; Chang, D. Metabolic Pathways and Male Fertility: Exploring the Role of Sertoli Cells in Energy Homeostasis and Spermatogenesis. Am. J. Physiol.-Endocrinol. Metab. 2025, 329, E160–E178. [Google Scholar] [CrossRef]
  13. Barkabi-Zanjani, S.; Ghorbanzadeh, V.; Aslani, M.; Ghalibafsabbaghi, A.; Chodari, L. Diabetes Mellitus and the Impairment of Male Reproductive Function: Possible Signaling Pathways. Diabetes Metab. Syndr. Clin. Res. Rev. 2020, 14, 1307–1314. [Google Scholar] [CrossRef]
  14. Huang, R.; Chen, J.; Guo, B.; Jiang, C.; Sun, W. Diabetes-Induced Male Infertility: Potential Mechanisms and Treatment Options. Mol. Med. 2024, 30. [Google Scholar] [CrossRef]
  15. Ricci, G.; Catizone, A.; Esposito, R.; Pisanti, F.A.; Vietri, M.T.; Galdieri, M. Diabetic Rat Testes: Morphological and Functional Alterations. Andrologia 2009, 41, 361–368. [Google Scholar] [CrossRef]
  16. Shi, H.; Korejo, N.A.; Kamboh, A.A.; Korejo, R.A.; Shi, F. Effects of Hyperthyroidism and Diabetes Mellitus on Spermatogenesis in Peri- and Post-Pubertal Mice. Front. Endocrinol. 2023, 14, 1191571. [Google Scholar] [CrossRef]
  17. Jégou, B. The Sertoli-Germ Cell Communication Network in Mammals. Int. Rev. Cytol. 1993, 147, 25–96. [Google Scholar] [PubMed]
  18. Atanassova, N.; McKinnell, C.; Walker, M.; Turner, K.J.; Fisher, J.S.; Morley, M.; Millar, M.R.; Groome, N.P.; Sharpe, R.M. Permanent Effects of Neonatal Estrogen Exposure in Rats on Reproductive Hormone Levels, Sertoli Cell Number, and the Efficiency of Spermatogenesis in Adulthood. Endocrinology 1999, 140, 5364–5373. [Google Scholar] [CrossRef]
  19. Atanassova, N.; Koeva, Y.; Bakalska, M.; Pavlova, E.; Nikolov, B.; Davidoff, M. Loss and Recovery of Androgen Receptor Protein Expression in the Adult Rat Testis Following Androgen Withdrawal by Ethane Dimethanesulfonate. Folia Histochem. Cytobiol. 2006, 44, 81–86. [Google Scholar]
  20. Alves, M.G.; Martins, A.D.; Cavaco, J.E.; Socorro, S.; Oliveira, P.F. Diabetes, Insulin-Mediated Glucose Metabolism and Sertoli/Blood-Testis Barrier Function. Tissue Barriers 2013, 1, e23992. [Google Scholar] [CrossRef] [PubMed]
  21. Barsiah, S.; Behnam-Rassouli, M.; Shahabipour, F.; Rostami, S.; Sabbaghi, M.A.; Momeni, Z.; Tavassoli, A.; Sahebkar, A. Evaluation of Testis Hormonal and Histopathological Alterations in Type I and Type II Diabetic Rats. J. Cell. Biochem. 2019, 120, 16775–16785. [Google Scholar] [CrossRef] [PubMed]
  22. He, W.; Liu, H.; Hu, L.; Wang, Y.; Huang, L.; Liang, A.; Wang, X.; Zhang, Q.; Chen, Y.; Cao, Y.; et al. Icariin Improves Testicular Dysfunction via Enhancing Proliferation and Inhibiting Mitochondria-Dependent Apoptosis Pathway in High-Fat Diet and Streptozotocin-Induced Diabetic Rats. Reprod. Biol. Endocrinol. 2021, 19. [Google Scholar] [CrossRef]
  23. Toprak, V.; Akalın, S.A.; Öcal, E.; Çavuş, Y.; Özdemir, İ. Histopathological Examination of the Protective Effect of Intense Exercise in Apoptotic Germ Cell Damage Due to Diabetes. Acta Cir. Bras. 2023, 38, e381423. [Google Scholar] [CrossRef]
  24. Kiani, M.; Soleimani Mehranjani, M.; Ali Shariatzadeh, M. Empagliflozin Reduces the Adverse Effects of Diabetes Mellitus on Testicular Tissue in Type 2 Diabetic Rats: A Stereological and Biochemical Study. Biochem. Pharmacol. 2024, 223, 116135. [Google Scholar] [CrossRef]
  25. Sajadi, E.; Dadras, S.; Bayat, M.; Abdi, S.; Nazarian, H.; Ziaeipour, S.; Mazini, F.; Kazemi, M.; Bagheri, M.; Valizadeh, A.; et al. Impaired Spermatogenesis Associated with Changes in Spatial Arrangement of Sertoli and Spermatogonial Cells Following Induced Diabetes. J. Cell. Biochem. 2019, 120, 17312–17325. [Google Scholar] [CrossRef]
  26. Zapryanova, S.; Pavlova, E.; Atanassova, N. Impact of Diabetes Mellitus Induced in Early Postnatal Life on Bax Protein Expression in Rat Testes. Acta Morphol. Anthropol. 2022, 29. [Google Scholar] [CrossRef]
  27. Ivanov, Rosen Investigation of spermatogenesis and oxidative stress in rat testis in conditions of experimental hyperglycaemia. Master’s Thesis, Sofia University “St. Kliment Ohridski”: Sofia, 2023.
  28. La Vignera, S.; Condorelli, R.; Vicari, E.; D’Agata, R.; Calogero, A.E. Diabetes Mellitus and Sperm Parameters. J. Androl. 2012, 33, 145–153. [Google Scholar] [CrossRef]
  29. Omolaoye, T.S.; Skosana, B.T.; Du Plessis, S.S. Diabetes Mellitus- Induction: Effect of Different Streptozotocin Doses on Male Reproductive Parameters. Acta Histochem. 2018, 120, 103–109. [Google Scholar] [CrossRef]
  30. Biasi, A.; Ambruosi, M.R.; Romano, M.Z.; Boccella, S.; Falvo, S.; Guida, F.; Aniello, F.; Maione, S.; Venditti, M.; Minucci, S. Impact of Type 1 Diabetes on Testicular Microtubule Dynamics, Sperm Physiology, and Male Reproductive Health in Rat. Int. J. Mol. Sci. 2025, 26, 4579. [Google Scholar] [CrossRef] [PubMed]
  31. Rato, L.; Alves, M.G.; Dias, T.R.; Cavaco, J.E.; Oliveira, P.F. Testicular Metabolic Reprogramming in Neonatal Streptozotocin-Induced Type 2 Diabetic Rats Impairs Glycolytic Flux and Promotes Glycogen Synthesis. J. Diabetes Res. 2015, 2015, 1–13. [Google Scholar] [CrossRef]
  32. Maresch, C.C.; Stute, D.C.; Ludlow, H.; Hammes, H.-P.; De Kretser, D.M.; Hedger, M.P.; Linn, T. Hyperglycemia Is Associated with Reduced Testicular Function and Activin Dysregulation in the Ins2 Akita+/− Mouse Model of Type 1 Diabetes. Mol. Cell. Endocrinol. 2017, 446, 91–101. [Google Scholar] [CrossRef] [PubMed]
  33. Azarniad, R.; Razi, M.; Hasanzadeh, S.; Malekinejad, H. Experimental Diabetes Negatively Affects the Spermatogonial Stem Cells’ Self-renewal by Suppressing GDNF Network Interactions. Andrologia 2020, 52. [Google Scholar] [CrossRef]
  34. Tavares, R.S.; Portela, J.M.D.; Sousa, M.I.; Mota, P.C.; Ramalho-Santos, J.; Amaral, S. High Glucose Levels Affect Spermatogenesis: An in Vitro Approach. Reprod. Fertil. Dev. 2017, 29, 1369. [Google Scholar] [CrossRef]
  35. Ballester, J.; Muñoz, M.C.; Domínguez, J.; Rigau, T.; Guinovart, J.J.; Rodríguez-Gil, J.E. Insulin-Dependent Diabetes Affects Testicular Function by FSH- and LH-Linked Mechanisms. J. Androl. 2004, 25, 706–719. [Google Scholar] [CrossRef] [PubMed]
  36. Fávaro, W.J.; Cagnon, V.H.A. Effect of Combined Hormonal and Insulin Therapy on the Steroid Hormone Receptors and Growth Factors Signalling in Diabetic Mice Prostate. Int. J. Exp. Pathol. 2010, 91, 537–545. [Google Scholar] [CrossRef] [PubMed]
  37. Nakane, Y.; Kemmochi, Y.; Ogawa, N.; Sasase, T.; Ohta, T.; Higami, Y.; Fukai, F. Hyperglycemia Contributes to the Development of Leydig Cell Hyperplasia in Male Spontaneously Diabetic Torii Rats. J. Toxicol. Pathol. 2020, 33, 121–129. [Google Scholar] [CrossRef]
  38. Shi, G.-J.; Li, Z.-M.; Zheng, J.; Chen, J.; Han, X.-X.; Wu, J.; Li, G.-Y.; Chang, Q.; Li, Y.-X.; Yu, J.-Q. Diabetes Associated with Male Reproductive System Damages: Onset of Presentation, Pathophysiological Mechanisms and Drug Intervention. Biomed. Pharmacother. 2017, 90, 562–574. [Google Scholar] [CrossRef] [PubMed]
  39. Wagner, I.V.; Klöting, N.; Savchuk, I.; Eifler, L.; Kulle, A.; Kralisch-Jäcklein, S.; Dötsch, J.; Hiort, O.; Svechnikov, K.; Söder, O. Diabetes Type 1 Negatively Influences Leydig Cell Function in Rats, Which Is Partially Reversible By Insulin Treatment. Endocrinology 2021, 162, bqab017. [Google Scholar] [CrossRef]
  40. Venditti, M.; Romano, M.Z.; Boccella, S.; Haddadi, A.; Biasi, A.; Maione, S.; Minucci, S. Type 1 Diabetes Impairs the Activity of Rat Testicular Somatic and Germ Cells through NRF2/NLRP3 Pathway-Mediated Oxidative Stress. Front. Endocrinol. 2024, 15. [Google Scholar] [CrossRef]
Figure 1. Absolute testis weight (A; mg) and relative testis weight/ (B; testis weight to body weight ratio) on days 25 and 45 of control and diabetic rats. Data represent mean value ± standard error (SE); * p < 0.05, ** p < 0.01 – statistical significance compared to the control value; a – statistically significant difference compared to NDM. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Figure 1. Absolute testis weight (A; mg) and relative testis weight/ (B; testis weight to body weight ratio) on days 25 and 45 of control and diabetic rats. Data represent mean value ± standard error (SE); * p < 0.05, ** p < 0.01 – statistical significance compared to the control value; a – statistically significant difference compared to NDM. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Preprints 170607 g001
Figure 2. Immunohistochemical localization of testicular angiotensin-converting enzyme (tACE) in testes of 45-day-old rats – controls (A) and prepubertally induced diabetic rats (B, C, D). Scale bar = 50 µm.
Figure 2. Immunohistochemical localization of testicular angiotensin-converting enzyme (tACE) in testes of 45-day-old rats – controls (A) and prepubertally induced diabetic rats (B, C, D). Scale bar = 50 µm.
Preprints 170607 g002
Figure 3. Absolute nuclear volume (ANV, mm3) of Sertoli cells (A) and total germ cells (B) on day 25 and day 45 of control and diabetic rats. Data represent mean value ± standard error (SE); * p < 0.05 – statistical significance compared to the control value; a – statistically significant difference compared to NDM. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Figure 3. Absolute nuclear volume (ANV, mm3) of Sertoli cells (A) and total germ cells (B) on day 25 and day 45 of control and diabetic rats. Data represent mean value ± standard error (SE); * p < 0.05 – statistical significance compared to the control value; a – statistically significant difference compared to NDM. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Preprints 170607 g003
Figure 4. Semen analysis of spermatozoa, isolated from both cauda epididymides of 65-day-old control and diabetic rats. Data represent mean value ± standard error (SE); ** p < 0.01 – statistical significance compared to the control value. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Figure 4. Semen analysis of spermatozoa, isolated from both cauda epididymides of 65-day-old control and diabetic rats. Data represent mean value ± standard error (SE); ** p < 0.01 – statistical significance compared to the control value. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Preprints 170607 g004
Figure 5. Immunohistochemical visualization with the marker enzyme 3β-hydroxysteroid dehydrogenase (3β-HSD) in Leydig cells in 25-day-old and 45-day-old controls and diabetic rats with neonatal (NDM) and prepubertal diabetes (PDM). Scale bar = 50 µm.
Figure 5. Immunohistochemical visualization with the marker enzyme 3β-hydroxysteroid dehydrogenase (3β-HSD) in Leydig cells in 25-day-old and 45-day-old controls and diabetic rats with neonatal (NDM) and prepubertal diabetes (PDM). Scale bar = 50 µm.
Preprints 170607 g005
Figure 6. Absolute nuclear volume (ANV) of Leydig cells (mm3) and serum testosterone levels (ng/mL) (A) and serum luteinizing hormone (mlU/mL) (B) on day 25 of control and diabetic rats. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Figure 6. Absolute nuclear volume (ANV) of Leydig cells (mm3) and serum testosterone levels (ng/mL) (A) and serum luteinizing hormone (mlU/mL) (B) on day 25 of control and diabetic rats. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Preprints 170607 g006
Figure 7. Absolute nuclear volume (ANV) of Leydig cells (mm3) and serum testosterone levels (ng/mL) (A) and serum luteinizing hormone (mlU/mL) (B) on day 45 of control and diabetic rats. ** p < 0.01 – statistical significance compared to the control value. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Figure 7. Absolute nuclear volume (ANV) of Leydig cells (mm3) and serum testosterone levels (ng/mL) (A) and serum luteinizing hormone (mlU/mL) (B) on day 45 of control and diabetic rats. ** p < 0.01 – statistical significance compared to the control value. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Preprints 170607 g007
Figure 8. Immunohistochemical expression of androgen receptor (AR) in Sertoli cells in 25- and 45-day-old control (A and D) and rats with neonatal DM (B and E) and prepubertal DM (C and F). A weaker intensity of reaction was observed in Sertoli cells of PDM rats. Note uniform intensity of the reaction in Sertoli cells of PDM rats aged 25 and 45 days. Scale bar = 50 µm. Negative control was done by preabsorption of primary antibody with peptide immunogen (picture inserted into control picture of day 25).
Figure 8. Immunohistochemical expression of androgen receptor (AR) in Sertoli cells in 25- and 45-day-old control (A and D) and rats with neonatal DM (B and E) and prepubertal DM (C and F). A weaker intensity of reaction was observed in Sertoli cells of PDM rats. Note uniform intensity of the reaction in Sertoli cells of PDM rats aged 25 and 45 days. Scale bar = 50 µm. Negative control was done by preabsorption of primary antibody with peptide immunogen (picture inserted into control picture of day 25).
Preprints 170607 g008
Table 1. Serum glucose levels (mmol/L) in control and diabetic animals on days 25 (nonfasting) and 45 (fasting). Data are presented as mean ± standard error (SE); * p < 0.05, ** p < 0.01 - statistical significance compared to the control value. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Table 1. Serum glucose levels (mmol/L) in control and diabetic animals on days 25 (nonfasting) and 45 (fasting). Data are presented as mean ± standard error (SE); * p < 0.05, ** p < 0.01 - statistical significance compared to the control value. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Day 25 Day 45
Control 10.86 ± 0.50 7.22 ± 0.84
NDM 11.49 ± 0.54 (6% ↑) 9.04 ± 1.27 (27% ↑)
PDM 14.00 ± 1.80 (30% ↑) 13.73 ± 3.72 * (93% ↑)
Table 2. Comparison of the absolute volumes of the seminiferous epithelium, lumen and interstitial tissue in control and diabetic groups (NDM and PDM) on days 25 and 45. Data represent mean value ± standard error (SE); * p < 0.05 – statistical significance compared to the control value. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Table 2. Comparison of the absolute volumes of the seminiferous epithelium, lumen and interstitial tissue in control and diabetic groups (NDM and PDM) on days 25 and 45. Data represent mean value ± standard error (SE); * p < 0.05 – statistical significance compared to the control value. NDM – neonatally-induced diabetes; PDM – prepubertally-induced diabetes.
Interstitium
(mm3)
Lumen
(mm3)
Seminiferous
epithelium
(mm3)
Day 25 Control 31.32 ± 2.32 14.09 ± 2.61 136.36 ± 10.39
NDM 28.03 ± 4.47 13.53 ± 2.47 131.11 ± 12.29
PDM 20.45 ± 2.52 * 8.30 ± 2.07 * 105.25 ± 10.07
Day 45 Control 116.27 ± 14.11 47.87 ± 7.74 637.86 ± 35.54
NDM 108.41 ± 6.62 105.73 ± 30.76 756.86 ± 34.30 *
PDM 96.38 ± 6.47 40.89 ± 10.22 478.73 ± 40.36 *
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.
Prerpints.org logo

Preprints.org is a free preprint server supported by MDPI in Basel, Switzerland.

Subscribe

Disclaimer

Terms of Use

Privacy Policy

Privacy Settings

© 2025 MDPI (Basel, Switzerland) unless otherwise stated